SCHEMBL10090164

SCHEMBL10090164

CCC(OC)c1ccco1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.38
MEN1 O00255 5/20 0.38
SLC6A2 P23975 1/20 0.37
SLC6A4 P31645 1/20 0.37
L3MBTL1 Q9Y468 3/20 0.36
GAA P10253 2/20 0.36
POLB P06746 2/20 0.35
PKM P14618 1/20 0.35
PTPN1 P18031 1/20 0.35
PTPN7 P35236 1/20 0.35
BLM P54132 1/20 0.35
ESR2 Q92731 1/20 0.35
HPGD P15428 2/20 0.35
GLA P06280 1/20 0.35
RECQL P46063 1/20 0.35
TP53 P04637 1/20 0.34
ALDH1A1 P00352 3/20 0.34
MAPT P10636 2/20 0.34
KDM4E B2RXH2 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1152090 0.85 SLC6A2 (0.38) KMT2AMEN1SLC6A2SLC6A4L3MBTL1
SCHEMBL2284051 0.82 SLC6A2 (0.39) KMT2AMEN1SLC6A2SLC6A4L3MBTL1
SCHEMBL5133451 0.81 MEN1 (0.40) KMT2AMEN1SLC6A2SLC6A4L3MBTL1
SCHEMBL5134036 0.80 MEN1 (0.40) KMT2AMEN1SLC6A2SLC6A4L3MBTL1
SCHEMBL13672226 0.79 SLC6A2 (0.35) KMT2AMEN1SLC6A2SLC6A4L3MBTL1
SCHEMBL11007405 0.79 SLC6A2 (0.38) KMT2AMEN1SLC6A2SLC6A4L3MBTL1
SCHEMBL5133109 0.78 MEN1 (0.40) KMT2AMEN1SLC6A2SLC6A4L3MBTL1
SCHEMBL10405528 0.77 ALDH1A1 (0.34) KMT2AMEN1SLC6A2SLC6A4L3MBTL1
SCHEMBL11007529 0.76 ALDH1A1 (0.33) KMT2AMEN1SLC6A2SLC6A4L3MBTL1
SCHEMBL11006336 0.76 ALDH1A1 (0.33) KMT2AMEN1SLC6A2SLC6A4L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8148541-B2 Rhodanine derivatives, a process for the preparation thereof and pharmaceutical composition containing the same KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2012-04-03 US disclosed
US-20090042872-A1 Rhodanine Derivatives, a Process for the Preparation Thereof and Pharmaceutical Composition Containing the Same KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042872-A1 Rhodanine Derivatives, a Process for the Preparation Thereof and Pharmaceutical Composition Containing the Same PTPRR, PTPRG, PTPRS KMT2A 2746/4885MEN1 4202/4885SLC6A2 2981/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.